Lisheng Peng

3.1k total citations
67 papers, 2.0k citations indexed

About

Lisheng Peng is a scholar working on Neurology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lisheng Peng has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 20 papers in Molecular Biology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Lisheng Peng's work include Multiple Sclerosis Research Studies (15 papers), Peripheral Neuropathies and Disorders (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (9 papers). Lisheng Peng is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Peripheral Neuropathies and Disorders (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (9 papers). Lisheng Peng collaborates with scholars based in China, United States and Australia. Lisheng Peng's co-authors include Min Dong, Xiaofen Zhong, Wei Qiu, Eric A. Johnson, William H. Tepp, Mangala M. Soundarapandian, Youming Lu, Ronnie P.‐A. Berntsson, Weihong Tu and Pål Stenmark and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

Lisheng Peng

65 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisheng Peng China 25 786 712 660 295 290 67 2.0k
Nico Melzer Germany 28 545 0.7× 430 0.6× 1.0k 1.6× 369 1.3× 406 1.4× 99 2.5k
Noel G. Carlson United States 31 1.2k 1.6× 562 0.8× 412 0.6× 458 1.6× 584 2.0× 79 2.8k
Anthony K. F. Liou United States 23 1.1k 1.4× 361 0.5× 450 0.7× 106 0.4× 603 2.1× 27 2.3k
Roopa S. Ghirnikar United States 13 961 1.2× 761 1.1× 378 0.6× 317 1.1× 780 2.7× 17 2.6k
Ellen Gerhardt Germany 28 999 1.3× 730 1.0× 910 1.4× 81 0.3× 278 1.0× 46 2.3k
Mingwei Li China 11 547 0.7× 364 0.5× 493 0.7× 240 0.8× 556 1.9× 52 1.7k
Kenneth S. Shindler United States 32 1.8k 2.3× 552 0.8× 467 0.7× 630 2.1× 446 1.5× 101 3.8k
Tim Chataway Australia 28 968 1.2× 656 0.9× 1.2k 1.8× 86 0.3× 316 1.1× 90 3.1k
Fulvio Celsi Italy 17 689 0.9× 389 0.5× 467 0.7× 48 0.2× 211 0.7× 49 1.6k
Shalina S. Ousman Canada 21 1.0k 1.3× 408 0.6× 248 0.4× 497 1.7× 728 2.5× 40 2.8k

Countries citing papers authored by Lisheng Peng

Since Specialization
Citations

This map shows the geographic impact of Lisheng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisheng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisheng Peng more than expected).

Fields of papers citing papers by Lisheng Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisheng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisheng Peng. The network helps show where Lisheng Peng may publish in the future.

Co-authorship network of co-authors of Lisheng Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Lisheng Peng. A scholar is included among the top collaborators of Lisheng Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisheng Peng. Lisheng Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Feng, Yifan, Dingding Shen, Ming Chen, et al.. (2022). Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice. Journal of Neuroinflammation. 19(1). 140–140. 19 indexed citations
3.
Wang, Yuge, Rui Li, Jinchi Liao, et al.. (2022). Anti-IgLON5 Encephalopathy with Concomitant Herpes Virus Encephalitis. NeuroImmunoModulation. 29(4). 515–519. 4 indexed citations
4.
Zhong, Xiaonan, Chen Chen, Xiaobo Sun, et al.. (2021). Whole‐exome sequencing reveals the major genetic factors contributing to neuromyelitis optica spectrum disorder in Chinese patients with aquaporin 4‐IgG seropositivity. European Journal of Neurology. 28(7). 2294–2304. 14 indexed citations
5.
Zhou, Yifan, Jingqi Wang, Yanyu Chang, et al.. (2020). Caffeic Acid Phenethyl Ester Protects against Experimental Autoimmune Encephalomyelitis by Regulating T Cell Activities. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 10 indexed citations
6.
Shan, Yilong, Sha Tan, Yinyao Lin, et al.. (2019). The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke. Journal of Neuroinflammation. 16(1). 242–242. 139 indexed citations
7.
Fang, Ling, Xinmei Kang, Zhen Wang, et al.. (2019). Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG. Neuroscience Bulletin. 35(5). 853–866. 11 indexed citations
8.
Zhong, Xiaonan, Yanyu Chang, Sha Tan, et al.. (2019). Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. BMC Neurology. 19(1). 94–94. 5 indexed citations
9.
Zhong, Xiaonan, Yifan Zhou, Yanyu Chang, et al.. (2019). Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients. Frontiers in Neurology. 10. 415–415. 24 indexed citations
10.
Ma, Qi, Hongyu Ruan, Lisheng Peng, et al.. (2017). Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity. Proceedings of the National Academy of Sciences. 114(41). E8760–E8769. 41 indexed citations
11.
Tao, Liang, Lisheng Peng, Ronnie P.‐A. Berntsson, et al.. (2017). Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors. Nature Communications. 8(1). 53–53. 45 indexed citations
12.
Shu, Yaqing, Yue Xu, Xiaobo Sun, et al.. (2017). Lipid Metabolism in Patients with Anti-N-Methyl-<smlcap>D</smlcap>-Aspartate Receptor Encephalitis. NeuroImmunoModulation. 24(4-5). 256–263. 5 indexed citations
13.
Lü, Tingting, Yuhang Pan, Lisheng Peng, et al.. (2017). Fatal familial insomnia with abnormal signals on routine MRI: a case report and literature review. BMC Neurology. 17(1). 104–104. 8 indexed citations
14.
Zhong, Xiaonan, Yifan Zhou, Tingting Lü, et al.. (2017). Infections in neuromyelitis optica spectrum disorder. Journal of Clinical Neuroscience. 47. 14–19. 29 indexed citations
15.
Peng, Lisheng, Huisheng Liu, Hongyu Ruan, et al.. (2013). Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival. Nature Communications. 4(1). 1472–1472. 77 indexed citations
16.
Berntsson, Ronnie P.‐A., Lisheng Peng, Min Dong, & Pål Stenmark. (2013). Structure of dual receptor binding to botulinum neurotoxin B. Nature Communications. 4(1). 2058–2058. 59 indexed citations
17.
Tu, Weihong, Xin Xu, Lisheng Peng, et al.. (2010). DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke. Cell. 140(2). 222–234. 408 indexed citations
18.
Zhong, Xiaofen, et al.. (2004). Secretion, purification, and characterization of a recombinant Aspergillus oryzae tannase in Pichia pastoris. Protein Expression and Purification. 36(2). 165–169. 68 indexed citations
19.
Peng, Lisheng, Xiaofen Zhong, Yuan Zhang, et al.. (2003). Molecular cloning, expression and characterization of three short chain α-neurotoxins from the venom of sea snake—Hydrophiinae Hydrophis cyanocinctus Daudin. Toxicon. 42(7). 753–761. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nico Melzer Breakdown of academic impact, for papers by Noel G. Carlson Breakdown of academic impact, for papers by Anthony K. F. Liou Breakdown of academic impact, for papers by Roopa S. Ghirnikar Breakdown of academic impact, for papers by Ellen Gerhardt Breakdown of academic impact, for papers by Mingwei Li Breakdown of academic impact, for papers by Kenneth S. Shindler Breakdown of academic impact, for papers by Tim Chataway Breakdown of academic impact, for papers by Fulvio Celsi Breakdown of academic impact, for papers by Shalina S. Ousman
Rankless by CCL
2026